Reata Pharmaceuticals
RETA
#2667
Rank
ยฃ4.88 B
Marketcap
ยฃ128.15
Share price
0.00%
Change (1 day)
330.94%
Change (1 year)

Revenue for Reata Pharmaceuticals (RETA)

Revenue in 2023 (TTM): ยฃ18.53 Million

According to Reata Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is ยฃ17.45 Million. In 2022 the company made a revenue of ยฃ1.83 Million a decrease over the revenue in the year 2021 that were of ยฃ8.51 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Reata Pharmaceuticals from 2015 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) ยฃ18.53 M911.97%
2022 ยฃ1.83 M-78.48%
2021 ยฃ8.51 M28.65%
2020 ยฃ6.61 M-67.28%
2019 ยฃ20.22 M-52.1%
2018 ยฃ42.21 M18.73%
2017 ยฃ35.55 M-11.99%
2016 ยฃ40.4 M18.99%
2015 ยฃ33.95 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA